79 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
and terms and conditions included in the contracts with the service providers. In addition, in certain circumstances, the determination of the nature … . The Company may invest its excess cash in mutual funds that are classified based on the nature of their underlying securities and their availability for use
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
current and future preclinical and clinical development projects. Due to the inherently unpredictable nature of preclinical and clinical development … is, by its nature, uncertain given that estimates depend on events over which we may not have control. If market and other conditions change from those
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
that are classified based on the nature of their underlying securities and their availability for use in current operations. The Company’s marketable
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
) to set the fees to be paid to such auditors in accordance with the volume and nature of their services.
In addition, the Company’s shareholders … and nature of their services. In addition, the Company’s shareholders will have the opportunity to hear from representatives of the Company’s management
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
13 Sep 23
Notice of Annual General Meeting of Shareholders
4:42pm
in accordance with the volume and nature of their services.
FOR
AGAINST
ABSTAIN
The undersigned hereby acknowledges receipt of the Notice of the Annual
6-K
EX-99.1
afyw nv1z
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
c9xxsr1izp8ixbdab6
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
0htdsj4ki6ag
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
tqy8p
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
v2pqoy6unv58q7lotolk
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
0q21x8wt
30 Dec 22
Report of Foreign Private Issuer
4:02pm
6-K
EX-99.1
lq06qq
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
fr8vb
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.1
1zx1ljmjo3222uj
5 Oct 22
Notice of Annual General Meeting of Shareholders
3:00pm
6-K
EX-99.1
rwxcg6
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.2
l62v8 9irra
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
hysw9f c9w9m20n7d
27 May 22
Condensed Consolidated Financial Statements
4:39pm
6-K
EX-99.2
0zn2y
27 May 22
Condensed Consolidated Financial Statements
4:39pm